Cong Yan

School of Medicine, Pathology & Laboratory Medicine

Empty picture place holder

Cong Yan

Email

Scopus Publication Detail

The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.



Structural analysis of metalloform-selective inhibition of methionine aminopeptidase

Sheng-Xue Xie; Wei-Jun Huang; Ze-Qiang Ma; Min Huang; Robert P. Hanzlik; Qi-Zhuang Ye (Profiled Author: Qizhuang Ye)

Acta Crystallographica Section D: Biological Crystallography. 2006;62(4):425-432.

Abstract

One of the challenges in the development of methionine aminopeptidase (MetAP) inhibitors as antibacterial and anticancer agents is to define the metal ion actually used by MetAP in vivo and to discover MetAP inhibitors that can inhibit the metalloform that is relevant in vivo. Two distinct classes of novel nonpeptidic MetAP inhibitors that are not only potent but also highly selective for either the Mn II or Co II form have been identified. Three crystal structures of Escherichia coli MetAP complexed with the metalloform-selective inhibitors 5-(2,5-dichlorophenyl)furan-2-carboxylic acid (2), 5-[2-(trifluoromethyl)phenyl]furan-2-carboxylic acid (3) and N-cyclopentyl-N-(thiazol-2-yl)oxalamide (4) have been solved and analysis of these structures has revealed the structural basis for their metalloform-selective inhibition. The Mn II-form selective inhibitors (2) and (3) both use their carboxylate group to coordinate with the two Mn II ions at the dinuclear metal site and both adopt a non-coplanar conformation for the two aromatic rings. The unique coordination geometry of these inhibitors may determine their Mn II-form selectivity. In contrast, the Co II-form selective inhibitor (4) recruits an unexpected third metal ion, forming a trimetallic enzyme-metal-inhibitor complex. Thus, an important factor in the selectivity of (4) for the Co II form may be a consequence of a greater preference for a softer N,O-donor ligand for the softer Co II. © 2006 International Union of Crystallography - all rights reserved.


PMID: 16552144